Literature DB >> 21063815

Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.

Ahmed A Aboelwafa1, Doaa Ahmed El-Setouhy, Aliaa Nabil Elmeshad.   

Abstract

The aim of this work was to investigate the effects of formulation variables on development of carvedilol (CAR) proniosomal gel formulations as potential transdermal delivery systems. Different non-ionic surfactants; polyoxyethylene alkyl ethers, namely Brij 78, Brij 92, and Brij 72; and sorbitan fatty acid esters (Span 60) were evaluated for their applicability in preparation of CAR proniosomal gels. A 2(3) full factorial design was employed to evaluate individual and combined effects of formulation variables, namely cholesterol content, weight of proniosomes, and amount of CAR added on performance of proniosomes. Prepared proniosomes were evaluated regarding entrapment efficiency (EE%), vesicle size, and microscopic examination. Also, CAR release through cellulose membrane and permeation through hairless mice skin were investigated. Proniosomes prepared with Brij 72 and Span 60 showed better niosome forming ability and higher EE% than those prepared with Brij 78 and Brij 92. Higher EE% was obtained by increasing both weight of proniosomes and amount of CAR added, and decreasing cholesterol content. Release rate through cellulose membrane was inversely affected by weight of proniosomes. In Span 60 proniosomes, on increasing percent of cholesterol, a decrease in release rate was observed. While in Brij 72 proniosomes, an enhancement in release rate was observed on increasing amount of CAR added. Permeation experiments showed that skin permeation was mainly affected by weight of proniosomes and that Span 60 proniosomal gels showed higher permeation enhancing effect than Brij 72. Proniosomal gel could constitute a promising approach for transdermal delivery of CAR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063815      PMCID: PMC3011071          DOI: 10.1208/s12249-010-9539-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  30 in total

1.  In vitro skin permeation of estradiol from various proniosome formulations.

Authors:  J Y Fang; S Y Yu; P C Wu; Y B Huang; Y H Tsai
Journal:  Int J Pharm       Date:  2001-03-14       Impact factor: 5.875

Review 2.  Novel mechanisms and devices to enable successful transdermal drug delivery.

Authors:  B W Barry
Journal:  Eur J Pharm Sci       Date:  2001-09       Impact factor: 4.384

3.  Effect of liposomes and niosomes on skin permeation of enoxacin.

Authors:  J Y Fang; C T Hong; W T Chiu; Y Y Wang
Journal:  Int J Pharm       Date:  2001-05-21       Impact factor: 5.875

4.  Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.

Authors:  M S El-Samaligy; N N Afifi; E A Mahmoud
Journal:  Int J Pharm       Date:  2005-12-13       Impact factor: 5.875

5.  Development of mucoadhesive patches for buccal administration of carvedilol.

Authors:  Y Vamshi Vishnu; K Chandrasekhar; G Ramesh; Y Madhusudan Rao
Journal:  Curr Drug Deliv       Date:  2007-01       Impact factor: 2.565

6.  Niosomes as carriers for tretinoin. I. Preparation and properties.

Authors:  Maria Manconi; Chiara Sinico; Donatella Valenti; Giuseppe Loy; Anna M Fadda
Journal:  Int J Pharm       Date:  2002-03-02       Impact factor: 5.875

7.  Lateral organization of liquid-crystalline cholesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices.

Authors:  J A Virtanen; M Ruonala; M Vauhkonen; P Somerharju
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

8.  Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.

Authors:  Zerrin Sezgin Bayindir; Nilufer Yuksel
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

9.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.

Authors:  Mahmoud Mokhtar; Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab
Journal:  Int J Pharm       Date:  2008-06-03       Impact factor: 5.875

10.  Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.

Authors:  Prabagar Balakrishnan; Srinivasan Shanmugam; Won Seok Lee; Won Mo Lee; Jong Oh Kim; Dong Hoon Oh; Dae-Duk Kim; Jung Sun Kim; Bong Kyu Yoo; Han-Gon Choi; Jong Soo Woo; Chul Soon Yong
Journal:  Int J Pharm       Date:  2009-04-24       Impact factor: 5.875

View more
  14 in total

1.  Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.

Authors:  Hiral Shah; Anroop B Nair; Jigar Shah; Praful Bharadia; Bandar E Al-Dhubiab
Journal:  Daru       Date:  2019-01-30       Impact factor: 3.117

2.  Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.

Authors:  Zerrin Sezgin-Bayindir; Mustafa Naim Antep; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2014-09-10       Impact factor: 3.246

3.  Evaluation of Metformin Hydrochloride Tailoring Bilosomes as an Effective Transdermal Nanocarrier.

Authors:  Heba F Salem; Mohammed M Nafady; Adel A Ali; Nermeen M Khalil; Amani A Elsisi
Journal:  Int J Nanomedicine       Date:  2022-03-17

4.  Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention.

Authors:  Mengbing Chen; Md Abdullah Shamim; Ayaz Shahid; Steven Yeung; Bradley T Andresen; Jeffrey Wang; Vijaykumar Nekkanti; Frank L Meyskens; Kristen M Kelly; Ying Huang
Journal:  Pharmaceutics       Date:  2020-11-27       Impact factor: 6.321

5.  Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect.

Authors:  Padmanabha Rao Amarachinta; Garima Sharma; Noufel Samed; Ananda Kumar Chettupalli; Madhusudhan Alle; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2021-04-09       Impact factor: 10.435

6.  Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness.

Authors:  Farid A Badria; Abdelaziz E Abdelaziz; Amira H Hassan; Abdullah A Elgazar; Eman A Mazyed
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

Review 7.  Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.

Authors:  Eliana B Souto; Joana F Fangueiro; Ana R Fernandes; Amanda Cano; Elena Sanchez-Lopez; Maria L Garcia; Patrícia Severino; Maria O Paganelli; Marco V Chaud; Amélia M Silva
Journal:  Heliyon       Date:  2022-02-11

8.  Highly active antiretroviral therapy conjugated silver nanoparticle ameliorates testicular injury in type-2 diabetic rats.

Authors:  Samuel Oluwaseun Olojede; Sodiq Kolawole Lawal; Ayobami Dare; Roshila Moodley; Carmen Olivia Rennie; Edwin C S Naidu; Onyemaechi Okpara Azu
Journal:  Heliyon       Date:  2021-12-09

9.  Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.

Authors:  Mohamed Y Zakaria; Eman Fayad; Fayez Althobaiti; Islam Zaki; Ali H Abu Almaaty
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

10.  Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment.

Authors:  Nadia M Morsi; Ahmed A Aboelwafa; Marwa H S Dawoud
Journal:  J Adv Res       Date:  2016-07-15       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.